Prostatype Genomics: 2023 Outlook - Redeye

Prostatype is making significant progress, with more than 10 Nordic clinics offering the Prostatype test to patients. In Europe, the number of clinics evaluating the test is at least 20. The company remains in the early launch stage but is also well-placed to deliver improved sales in 2023.

Länk till analysen i sin helhet: https://www.redeye.se/research/878860/prostatype-genomics-2023-outlook?utm_source=finwire&utm_medium=RSS